BRIEF—Mathai Mammen quits R&D role at J&J

US healthcare giant Johnson & Johnson said yesterday that Dr Mathai Mammen has decided to leave his position as executive vice president, Pharmaceuticals, R&D, and pursue other opportunities outside of the company.

Dr William Hait will serve as interim head of the Pharmaceutical R&D organization until new leadership is identified.

Dr Mammen joined Johnson & Johnson in 2017 as global head of Janssen R&D, and the company thanks Dr Mammen for his contributions in advancing Johnson & Johnson’s industry-leading portfolio.